Filing Details

Accession Number:
0001850902-22-000035
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-11-17 19:46:47
Reporting Period:
2022-05-13
Accepted Time:
2022-11-17 19:46:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1850902 Alpha Teknova Inc. TKNO In Vitro & In Vivo Diagnostic Substances (2835) 943368109
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1862135 Lisa Hood C/O Alpha Teknova, Inc.
2451 Bert Drive
Hollister CA 95023
Chief People Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-05-13 772 $10.93 31,234 No 4 P Direct
Common Stock Acquisiton 2022-11-14 2,046 $4.23 33,280 No 4 P Direct
Common Stock Disposition 2022-11-15 2,046 $5.28 31,234 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Acquisiton 2022-11-15 40,498 $0.00 40,498 $5.36
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
40,498 2032-11-15 No 4 A Direct
Footnotes
  1. The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Alpha Teknova, Inc. 2021 Employee Stock Purchase Plan (the ESPP), for the ESPP purchase period commencing on November 15, 2021, and ending on May 14, 2022 (the Prior Purchase Period). This transaction is also exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at the lesser of (i) 85% of fair market value on the first trading day of the Prior Purchase Period, and (ii) 85% of fair market value on the last day of the Prior Purchase Period, in each case rounded up to the nearest whole cent per share.
  2. The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Alpha Teknova, Inc. 2021 Employee Stock Purchase Plan (the ESPP), for the ESPP purchase period commencing on May 15, 2022, and ending on November 14, 2022 (the Purchase Period). This transaction is also exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at the lesser of (i) 85% of fair market value on the first trading day of the Purchase Period, and (ii) 85% of fair market value on the last day of the Purchase Period, in each case rounded up to the nearest whole cent per share.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.27 to $5.36, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote to this Form 4.
  4. The number of shares subject to the option shall vest in 48 equal monthly installments on the same day of each month after November 15, 2022, the date of grant.